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ABSTRACT  
A simple, precise and accurate UV Spectrophotometric method was developed for 
the estimation of Paroxetine hydrochloride. The developed method obeyed Beer-
Lambert’s law in the concentration range of 5-30 µg/ml with a correlation 
coefficient of 0.995. The recovery study was carried out at three different levels 
and was found to be satisfactory. The percent amount of drug estimated by this 
method is 100%, found to be in good agreement with label claim of marketed 
tablet formulation. The validation parameters like linearity, precision, accuracy, 
robustness and ruggedness were studied and were found to be within limits. The 
proposed method can be adopted for routine quality control analysis of 
estimation of Paroxetine hydrochloride in pharmaceutical formulation.  
INTRODUCTION
Paroxetine hydrochloride is a potent and selective 
serotonin reuptake inhibitor[1,2]. Chemically 
Paroxetine hydrochloride is (-)-trans-4R-(4'-
fluorophenyl)-3S-[(3',4'-methylenedioxyphenoxy) 
methyl] piperidine hydrochloride hemihydrate (Fig. 
1)[3]. Paroxetine hydrochloride is indicated for the 
treatment of depression, obsessive-compulsive 
disorder, panic disorder and social phobia[4]. 
Paroxetine acts by potentiation of serotonergic 
activity in the central nervous system resulting 
from inhibition of neuronal reuptake of serotonin 
(5-hydroxy-tryptamine, 5-HT)[5].  
Literature survey reveals that very few UV 
Spectrophotometric methods were reported for the 
determination of Paroxetine hydrochloride[6]. The 
present study report a simple, rapid, precise and 
accurate UV Spectrophotometric method for the 
estimation of Paroxetine hydrochloride in bulk drug 
and in tablet dosage form and the developed 
method was validated as per ICH guidelines[7]. 
MATERIALS AND METHODS 
Chemicals and Reagents 
Pharmaceutical grade Paroxetine hydrochloride 
was obtained as gift sample from Spectrum Pharma 
Research Solutions, Hyderabad, India. Paroxetine 
hydrochloride (PARADISE XR 12.5) tablets were 
purchased from local market. Methanol (AR grade) 
was purchased from E.Merck (India) Ltd., Mumbai, 
India and was used as solvent. Fresh purified 
distilled water was used throughout the 
experiment. 
Instruments  
UV Spectrophotometer: Shimadzu-UV1800 
Double Beam UV-Visible Spectrophotometer  
Weighing balance: Shimadzu-BL220H Digital 
Weighing Balance 
Preparation of standard stock solution 
10 mg of Paroxetine hydrochloride was accurately 
weighed, transferred to 10 ml volumetric flask and 
dissolved in 7 ml of methanol. Sonicated the 
solution for few minutes and dissolved the drug 
completely. Then it was filtered through 0.45 μ 
filter and the volume was made up to 10 ml with 
methanol to get a concentration of 1 mg/ml stock 
solution. Further pipetted 1.0 ml of the above stock 
solution into a 10 ml volumetric flask and diluted 
up to the mark with diluent to obtain the 
concentrations of 100 µg/ml. Different aliquots 
were taken from standard stock solution and 
diluted with methanol separately to prepare series 
of concentrations from 5-30 µg/ml.  
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Preparation of sample solution  
Twenty tablets of Paroxetine hydrochloride were 
weighed, finely powdered and calculated the 
average weight. An accurately weighed portion of 
powder sample equivalent to 10 mg of Paroxetine 
hydrochloride was transferred to 10 ml volumetric 
flask and dissolved in 7 ml of the methanol. 
Sonicated the solution for few minutes and 
dissolved the drug completely. Then it was filtered 
through 0.45 μ filter and the volume was made up 
to 10 ml with methanol. Further pipetted 2 ml of the 
above stock solution into a 10 ml volumetric flask 
and diluted up to the mark with methanol to obtain 
the concentration of 20 µg/ml. 
Selection of solvent 
The solubility of Paroxetine hydrochloride was 
determined in a variety of polar and non-polar 
solvents. Based on the solubility of the compound 
finally methanol was selected due to its positive 
results. Absorbance was measured at selected 
maximum wave length (200 nm to 400 nm) based on 
the overlain spectra of drug spectrum. 
Selection of wave length  
The selection of wave length for the estimation of 
Paroxetine hydrochloride, a suitable diluted stock 
solution contains 20 µg/ml and the solution were 
scanned between 200-400 nm by using methanol as 
blank. From the overlain spectra, by the observation 
of spectral characteristics of Paroxetine 
hydrochloride, the wave length selected was 235 
nm. The stability was performed by measuring the 
absorbance of same solution at different intervals. It 
was observed that Paroxetine hydrochloride in 
methanol were stable for more than 4 hours at all 
the selected wave length.  
Specificity  
The wave length was specific for Paroxetine 
hydrochloride according to its structure. A study 
conducted to establish specificity of blank and 
placebo using the spectrophotometric conditions 
defined for the proposed method. It was found that 
there is no interference due to excipients in the 
tablet formulation and also found good correlation 
between the absorbances of standard and sample. 
Linearity  
Working standard solutions of Paroxetine 
hydrochloride were prepared from the standard 
solution of 100 µg/ml. Different aliquots were taken 
from standard stock solution and diluted with 
methanol separately to prepare 5 µg/ml, 10 µg/ml, 
15 µg/ml, 20 µg/ml, 25 µg/ml and 30 µg/ml 
solutions respectively. Linearity was evaluated by 
taking different concentrations in the range of 5-30 
µg/ml and the absorbances were measured. Each 
measurement was carried out in triplicate. The 
correlation coefficient was found to be 0.995. 
Linearity was proven by linear regression analysis 
by the least square method. By taking the 
concentration and absorbance values calibration 
curve was plotted taking concentration on x‐axis 
and absorbance on y‐axis which showed a straight 
line in the calibration curve obeyed linearity. The 
calibration curve of Paroxetine hydrochloride was 
shown in Fig. 2. The linearity results were furnished 
in Table 1. 
Precision  
The concentration used for the precision studies is 
20 µg/ml and was assumed as 100%. The precision 
of the method was determined by intra-day and 
inter-day analysis i.e., the analysis of formulation 
was repeated six times in the same day and on six 
consecutive days. The amount of drug was 
determined and %RSD was calculated. The %RSD of 
Paroxetine hydrochloride should not be more than 
2.0. The intra-day and inter-day precision results 
were furnished in Table 2 and Table 3. 
Accuracy  
The accuracy of the method was determined by 
standard addition method. A known amount of 
standard drug was added to the fixed amount of 
pre-analyzed tablet formulation solution of 
Paroxetine hydrochloride and the procedure was 
followed as per the analysis of formulation. Percent 
recovery was calculated by comparing the 
absorbance before and after the addition of the 
standard drug. The standard addition method was 
performed at three concentration levels of 50%, 
100% and 150%. The solutions were analyzed in 
triplicate at each level as per the proposed method. 
Each recovery was made three times and the 
average value was considered. The percent 
recovery at each level was calculated. The results of 
recovery studies of Paroxetine hydrochloride were 
furnished in Table 4.  
Robustness 
The robustness study was performed by slight 
modification in method parameters of Paroxetine 
hydrochloride. Sample of Paroxetine hydrochloride 
at 20 µg/ml concentration were analyzed under 
these changed experimental conditions. It was 
observed that there were no marked changes in 
absorbances, which demonstrated that the 
developed method was robust in nature.  
Ruggedness 
Ruggedness of the method was confirmed by the 
analysis of formulation was done by different 
analysts. Sample of Paroxetine hydrochloride at 20 
µg/ml concentration were analyzed by different 
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analysts. It was observed that there were no 
marked changes in absorbances, which 
demonstrated that the developed method was 
rugged in nature.  
Assay 
Instrument was allowed to stand for 10 minutes to 
stabilize. Then the instrument parameters viz. start 
wavelength, end wavelength data interval, scan 
speed, slit width and sample information were 
entered in the instrument. Then base line correction 
was performed by keeping the blank in both the 
sample and reference compartments. The 
absorbances of standard solutions and sample 
solutions were determined against blank 
(methanol) at 235 nm. Paroxetine hydrochloride 
was assayed from the commercial tablet 
formulations by calibration curve drawn between 
absorbance and concentration of Paroxetine 
hydrochloride with label claim of 10 mg. Sample of 
Paroxetine hydrochloride at 20 µg/ml 
concentration was used for estimation. The assay 
results were furnished in Table 5.  
RESULTS AND DISCUSSION 
The absorption spectrum of Paroxetine 
hydrochloride in methanol was found to be 235 nm. 
Paroxetine hydrochloride was linear with the 
concentration range of 5-30 µg/ml. The regression 
equation of the linearity plot of concentration of 
Paroxetine hydrochloride over its peak area was 
found to be y=0.01x+0.009 (R2=0.995), where x is 
the concentration of Paroxetine hydrochloride 
(μg/ml) and y is the corresponding absorbance. The 
%RSD for intra-day precision and inter-day 
precision of Paroxetine hydrochloride was found to 
be 1.10 and 1.74. The percent recovery of 
Paroxetine hydrochloride was in the range of 97.2% 
to 101.3% and the % mean recovery was found to 
be 98.93% by the proposed method. The high 
percentage of recovery indicates that the proposed 
method is highly accurate. The % assay of 
Paroxetine in commercial tablet formulations was 
100%, indicating that excipients used in tablet 
formulations did not interfere with the estimation 
of the drug Paroxetine hydrochloride by the 
proposed UV spectrophotometric method. The 
assay showed that the drug content of this product 
to be in accordance with the labeled claim.  
CONCLUSION 
In the present investigation, an attempt has been 
made to develop simple, sensitive, precise and 
accurate UV spectrophotometric method for the 
determination of Paroxetine hydrochloride in bulk 
sample and pharmaceutical formulations. The 
advantage of proposed method was its simple 
procedure for its sample preparation and more 
economical. The method was validated as per 
International Conference on Harmonization 
Guidelines. The satisfying recoveries, low coefficient 
of variation and assay results confirmed the 
suitability of proposed method for the routine 
quality control analysis of Paroxetine hydrochloride 
in pharmaceutical formulations.  
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Fig. 1: Chemical structure of Paroxetine hydrochloride 
 
Fig.2: Calibration curve of Paroxetine hydrochloride 
Table 1: Linearity results of Paroxetine hydrochloride 
S. No. Concentration (µg/ml) Absorbance 
1. 0 0 
2. 5 0.061 
3. 10 0.121 
4. 15 0.156 
5. 20 0.211 
6. 25 0.261 
7. 30 0.301 
Slope 0.01 
Intercept 0.009 
Correlation Coefficient 0.995 
Table 2: Intra-day precision results of Paroxetine hydrochloride 
S. No.  Time (Hours) Absorbance 
1 0 0.214 
2 3 0.217 
3 6 0.213 
4 9 0.215 
5 12 0.211 
6 15 0.211 
y = 0.01x + 0.009
R² = 0.995
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Mean 0.213 
SD 0.00235 
%RSD 1.10 
Table 3: Inter-day precision results of Paroxetine hydrochloride 
S. No.  Time (Days) Absorbance 
1 1 0.213 
2 2 0.209 
3 3 0.215 
4 4 0.211 
5 5 0.219 
6 6 0.217 
Mean 0.214 
SD 0.00374 
%RSD 1.74 
Table 4: Recovery studies for Paroxetine hydrochloride 
Level Standard 
concentration 
(µg/ml)  
Concentration 
added  
(µg/ml) 
Concentration 
found  
(µg/ml) 
% Recovery % Mean 
recovery 
50% 10 5 4.86 97.2  
98.93 100% 10 10 10.33 101.3 
150% 10 15 14.7 98.0 
Table 5: Assay results of Paroxetine hydrochloride  
Formulation Label claim Amount found %Assay 
PARADISE XR 12.5 12.5 mg 12.5 mg 100% 
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